Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis

• Status: Completed
• Trial end date: 2017-04-05
• Target enrollment: 0
• Participant gender: All

Summary

Study assessing cognitive function and physical activity in people with relapsing remitting multiple sclerosis.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayer
• Treatments: Interferon beta-1b; Interferon-beta; Interferons

Criteria

Inclusion Criteria:

• Patients with Relapsing Remitting Multiple Sclerosis (RRMS), and treated with Betaferon, with the decision for treatment made at the discretion of the attending physician, documented with a prescription of Betaferon by the physician

• EDSS 0 - 6

• Written informed consent

Exclusion Criteria:

• Patients who do not meet the local indication criteria for Betaferon treatment.

• Contraindications listed in the local SmPCs have to be considered.

• Patients with a history of severe head trauma.

• Patients with alcohol and/or drug abuse.

• Patients with mental retardation.

• Patients with learning disability.